Previous 10 | Next 10 |
home / stock / tlt / tlt articles
Every cycle brings new opportunities; now that the Federal Reserve (the Fed) is looking to cut interest rates in 2024, the market could be getting ...
The bond market is showing new signs of unpredictability as expectations over Fed rate cuts shift with every new piece of economic data. Last week,...
The number of U.S. citizens filing new claims for unemployment benefits fell more sharply than expected last week, underpinning the Federal Reserve...
Wall Street witnessed slight gains at midday on Monday, with investors eagerly awaiting a series of critical earnings reports, the Federal Reserve&...
Retail sales reached new heights in December 2023, defying expectations and demonstrating the strong resilience of U.S. consumer demand. The U.S. ...
Over the past twenty days of trading, iShares 20+ Year Treasury Bond ETF (NASDAQ: TLT), from December 06, 2023 to January 04, 2024 there is a pote...
After a tumultuous cycle in the markets, the S&P 500 is on the brink of a breakout as investor sentiment shifts, according to a senior portfoli...
U.S. 30-year Treasury yields fell below the 4% mark on Wednesday, reaching their lowest level since late July. The decline in long-dated Treasury y...
The CEO of Howard Capital Management, Vance Howard, has made predictions about the financial markets that may surprise some investors. Despite the ...
News, Short Squeeze, Breakout and More Instantly...
iShares 20+ Year Treasury Bond ETF Company Name:
TLT Stock Symbol:
NASDAQ Market:
TORONTO, ON / ACCESSWIRE / July 8, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic Compounds (" PDCs ...
TORONTO, ON / ACCESSWIRE / June 20, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...
TORONTO, ON / ACCESSWIRE / June 19, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...